Related Experiment Video

Updated: Jun 21, 2026

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
09:37

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

Haptoglobin: A major susceptibility gene for diabetic vascular complications

Tal Szafranek1, Stuart Marsh, Andrew P Levy

  • 1Rappaport Faculty of Medicine, Technion-Israel Institute of Technology and.

Experimental and Clinical Cardiology
|August 4, 2009
PubMed

Insights

Haptoglobin phenotype may predict diabetes complications. Different haptoglobin types influence antioxidant capacity, blood filtering, and immune responses, suggesting it

Area of Science:

  • Genetics and Medicine
  • Endocrinology and Metabolism

Background:

  • Diabetes mellitus (DM) complications, including blindness and end-stage renal disease, pose significant health burdens.
  • The genetic factors influencing the development of diabetic vascular complications are increasingly recognized.
  • Previous research suggests a link between haptoglobin phenotype and diabetic vascular disorders.

Purpose of the Study:

  • To explore the role of haptoglobin phenotype as a predictor of diabetes-related vascular complications.
  • To elucidate the mechanisms by which haptoglobin phenotype may influence the pathogenesis of diabetic vascular disease.

Main Methods:

  • Analysis of haptoglobin protein products and their variations across different phenotypes (1-1, 2-1, 2-2).
  • Evaluation of the antioxidant capacity of different haptoglobin alleles.
  • Assessment of the differential sieving properties of haptoglobin polymers.
  • Investigation of the immunomodulatory functions associated with various haptoglobin types.

Main Results:

  • Haptoglobin phenotype is identified as a potential risk factor for vascular disease in diabetic patients.
  • Differences in antioxidant capacity among haptoglobin alleles contribute to varying risks.
  • Distinct sieving properties of haptoglobin polymers and differential immunomodulatory functions are observed across phenotypes.

Conclusions:

  • Haptoglobin phenotype offers new insights into the pathogenesis of diabetic vascular complications.
  • Haptoglobin phenotype represents a novel risk factor for vascular complications in diabetes mellitus.
  • Targeting haptoglobin pathways may present a new therapeutic strategy for preventing diabetic vascular diseases.

Keywords:
ComplicationsDiabetesHaptoglobinPolymorphism

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...